Genpharmasec Ltd — Important, 11-02-2026: Company Update

GENPHARMASEC LIMITED has published its financial results for the quarter ended December 31, 2025. On a consolidated basis, the company reported total income from operations of ₹40.81 Cr. The net loss after tax stood at ₹0.83 Cr, resulting in an EPS of (₹0.02). For standalone results, total income from operations was ₹7.44 Cr, with a net profit after tax of ₹0.76 Cr. These figures provide stakeholders with an update on the company's financial health and operational performance for the recent quarter.